Johnson & Johnson
Holdings as of Jun 30, 2026 · filed Aug 6, 2026
| # | Holding | Value | % Port. | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Protagonist Therapeutics Inc | $300220852 | 37.59% | — | Held |
| 2 | Nanobiotix | $212017863 | 26.55% | — | Held |
| 3 | Meiragtx Hldgs Plc | $89720775 | 11.23% | — | Held |
| 4 | Rapport Therapeutics Inc | $74360823 | 9.31% | — | Held |
| 5 | Contineum Therapeutics Inc | $32438645 | 4.06% | — | Held |
| 6 | Legend Biotech Corp | $23525244 | 2.95% | — | Held |
| 7 | Cvrx Inc | $20687786 | 2.59% | — | Held |
| 8 | Xencor Inc | $12043798 | 1.51% | — | Held |
| 9 | Cerebras Systems Inc | $11842506 | 1.48% | — | NEW BUY |
| 10 | Fate Therapeutics Inc | $9123473 | 1.14% | — | Held |
| 11 | Procept Biorobotics Corp | $8082263 | 1.01% | — | Held |
| 12 | Neumora Therapeutics Inc. | $3144057 | 0.39% | — | Held |
| 13 | Vor Biopharma Inc | $989206 | 0.12% | — | Held |
| 14 | Standard Biotools Inc | $256655 | 0.03% | — | Held |
| 15 | Adicet Bio Inc | $196811 | 0.02% | — | Held |
Closed last quarter
Rallybio Corporation
Nano-X Imaging Ltd.
Holdings disclosed quarterly to the SEC on Form 13-F and may be up to 45 days old. Values as reported. For research only — not investment advice.